Xylem said revenue for Q3 2025 was $2,268 million, an increase of $164 million or 7.8% compared with the prior year, with organic revenue growth of $145 million or 6.9%.

1. 01

   Xylem said revenue for Q3 2025 was $2,268 million, an increase of $164 million or 7.8% compared with the prior year, with organic revenue growth of $145 million or 6.9%.

2. 02

   The company said operating income for Q3 2025 was $334 million with an operating margin of 14.7%, and adjusted EBITDA was $527 million with an adjusted EBITDA margin of 23.2%, an increase of $54 million.

3. 03

   Xylem said total backlog as of September 30, 2025 was $4,819 million, a decrease of $434 million or 8.3% compared with backlog of $5,253 million as of September 30, 2024. The company cited increased revenue outpacing order intake and contract wins as factors in the decrease.

4. 04

   Xylem raised its full-year 2025 revenue growth guidance to 5% to 6% and organic revenue growth guidance to 4% to 5%. The company said it provided this guidance amid geopolitical, trade, macroeconomic and regulatory uncertainties.

Key figures

Quarter ended September 30, 2025

Revenue

$2.3B

Operating income

$334M

Net income

$227M

EPS

$0.93

Gross profit

$883M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.